Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
April 22, 2026
Censoring patterns and inconsistent results in checkpoint inhibitor and adjuvant BCG trials for high-risk bladder cancer
Dries Develtere, Petros Tsantoulis, Timothée Olivier
Revue Medicale Suisse
|
June 22, 2017
[Follow-up of the long-term cancer survivor]
Francesco Sciotto, Céline Py, Petros Tsantoulis
Revue Medicale Suisse
|
July 19, 2016
[Bioinformatics: a key role in oncology]
Timothée Olivier, Pierre Chappuis, Petros Tsantoulis
Frontiers in Oncology
|
May 6, 2022
The Landscape of Immunotherapy Resistance in NSCLC
Daniele Frisone, Alex Friedlaender, Alfredo Addeo, et al.
Cancer Genomics & Proteomics
|
August 30, 2020
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer
Mathieu Chevallier, Petros Tsantoulis, Alfredo Addeo, et al.
Future Oncology (London, England)
|
October 23, 2024
Rates of febrile neutropenia and its causes in the real world
Maxime Borgeaud, Simona Perano, Alfredo Addeo, et al.
JCEM Case Reports
|
August 27, 2025
Concomitant Immune Checkpoint Inhibitors Induced Central and Primary Adrenal Insufficiency: A Diagnostic Challenge
Alberto Nascè, Sophie Leboulleux, Simina Chiriac, et al.
Frontiers in Oncology
|
April 19, 2021
The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy
Alex Friedlaender, Petros Tsantoulis, Mathieu Chevallier, et al.
Frontiers in Oncology
|
October 31, 2025
Case Report: Trametinib in the treatment of patients with metastatic lung adenocarcinoma harboring <i>NF1</i> mutation: a case series and literature review
Floryane Kim, Maxime Borgeaud, Claudio De Vito, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
October 6, 2025
Claudine Burton-Jeangros, Monica Aceti, Pierre O Chappuis, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
European Journal of Cancer (Oxford, England : 1990)
|
April 22, 2026
Censoring patterns and inconsistent results in checkpoint inhibitor and adjuvant BCG trials for high-risk bladder cancer
Dries Develtere, Petros Tsantoulis, Timothée Olivier
Revue Medicale Suisse
|
June 22, 2017
[Follow-up of the long-term cancer survivor]
Francesco Sciotto, Céline Py, Petros Tsantoulis
Revue Medicale Suisse
|
July 19, 2016
[Bioinformatics: a key role in oncology]
Timothée Olivier, Pierre Chappuis, Petros Tsantoulis
Frontiers in Oncology
|
May 6, 2022
The Landscape of Immunotherapy Resistance in NSCLC
Daniele Frisone, Alex Friedlaender, Alfredo Addeo, et al.
Cancer Genomics & Proteomics
|
August 30, 2020
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer
Mathieu Chevallier, Petros Tsantoulis, Alfredo Addeo, et al.
Future Oncology (London, England)
|
October 23, 2024
Rates of febrile neutropenia and its causes in the real world
Maxime Borgeaud, Simona Perano, Alfredo Addeo, et al.
JCEM Case Reports
|
August 27, 2025
Concomitant Immune Checkpoint Inhibitors Induced Central and Primary Adrenal Insufficiency: A Diagnostic Challenge
Alberto Nascè, Sophie Leboulleux, Simina Chiriac, et al.
Frontiers in Oncology
|
April 19, 2021
The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy
Alex Friedlaender, Petros Tsantoulis, Mathieu Chevallier, et al.
Frontiers in Oncology
|
October 31, 2025
Case Report: Trametinib in the treatment of patients with metastatic lung adenocarcinoma harboring <i>NF1</i> mutation: a case series and literature review
Floryane Kim, Maxime Borgeaud, Claudio De Vito, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
October 6, 2025
Claudine Burton-Jeangros, Monica Aceti, Pierre O Chappuis, et al.
Page
of 6